James S Scibetta Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James S Scibetta.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James S Scibetta. James S Scibetta is a President in Pacira Pharmaceuticals, Inc. ($PCRX) and a President & CFO in Pacira Pharmaceuticals, Inc. ($PCRX) and a SVP, Chief Financial Officer in Pacira Pharmaceuticals, Inc. ($PCRX) and a in Aquestive Therapeutics, Inc. ($AQST) and a Director in Matinas BioPharma Holdings, Inc. ($MTNB).
Address: C/O BIOENVISION, INC. 345 PARK AVENUE, 41ST FLOOR NEW YORK 10154 NY
Companies in which James S Scibetta is an Insider
Aquestive Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James S Scibetta:
Holdings: 19,425 shares
Latest Transaction: Jun 17 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Matinas BioPharma Holdings, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James S Scibetta: Director
Holdings: 621,158 shares
Current Value: $1,608,799
Latest Transaction: Nov 10 2020
$MTNB Market Capitalization: $149.76M
$MTNB Previous Close: $2.59
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Pacira BioSciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James S Scibetta: President & CFO, SVP, Chief Financial Officer
Holdings: 25,118 shares
Current Value: $1,048,677
Latest Transaction: Jun 07 2017
$PCRX Market Capitalization: $1.57B
$PCRX Previous Close: $41.75
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of James S Scibetta
Sentiment: All, AQST, MTNB, PCRX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17 2021 | AQST | Aquestive Therapeu ... | Scibetta James S | Option Exercise | A | 4.04 | 20,000 | 80,800 | 20,000 | ||
| Nov 10 2020 | MTNB | Matinas BioPharma ... | Scibetta James S | Director | Option Exercise | A | 0.82 | 122,605 | 100,536 | 122,605 | |
| Jun 24 2020 | MTNB | Matinas BioPharma ... | Scibetta James S | Director | Buy | J | 0.00 | 3,600 | 0 | 621,158 | 617.6 K to 621.2 K (+0.58 %) |
| Jun 18 2020 | AQST | Aquestive Therapeu ... | Scibetta James S | Option Exercise | A | 5.30 | 14,000 | 74,200 | 14,000 | ||
| Oct 02 2019 | MTNB | Matinas BioPharma ... | Scibetta James S | Director | Buy | J | 0.00 | 2,400 | 0 | 609,298 | 606.9 K to 609.3 K (+0.40 %) |
| Oct 02 2019 | MTNB | Matinas BioPharma ... | Scibetta James S | Director | Grant | A | 0.00 | 29,739 | 0 | 606,898 | 577.2 K to 606.9 K (+5.15 %) |
| Aug 22 2019 | AQST | Aquestive Therapeu ... | Scibetta James S | Buy | P | 3.81 | 900 | 3,429 | 31,635 | 30.7 K to 31.6 K (+2.93 %) |